BROOKLYN, NY / ACCESS Newswire / November 10, 2025 / IEH Corporation (OTC:IEHC) today filed with the Securities and Exchange Commission (SEC) its quarterly report on Form 10-Q for the 2nd fiscal ...
PwdRx novel drug delivery platform demonstrated superior bioavailability and accelerated absorption of cannabinoids in ...
Venus NOVA is supported by the Venus Jumpstart Program, a 30-day roadmap providing advanced clinical education, marketing enablement, and strategic implementation. This ensures seamless integration ...
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the completion of the submission of its New Drug ...
Prescription Drug User Fee Act (PDUFA) target action date set for June 29, 2026If approved, ZORYVE cream 0.3% would be the first and only topical ...
NDA based on data from global ARROS-1 Phase 1/2 clinical trial FDA assigns PDUFA target action date of September 18, 2026 CAMBRIDGE, Mass., Nov. 19, 2025 /PRNewswire/ ...
This acceptance follows Sangamo’s meeting with the FDA in October 2025 to discuss the proposed efficacy and safety data package for isaralgagene civaparvovec where, in the meeting minutes, among other ...
International students in the US face sudden SEVIS terminations, jeopardizing their lawful stay and work authorization ...
An investigation by Belfast Live found several letting agents who were still listing fees to tenants for property ...
A psychiatrist shortage, frozen Medicaid payments and an annual operating loss have contributed to the center’s decision to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback